Patient usable emergency medical kit

• US 7,086,397 B2
• Filed: 02/16/2002
• Issued: 08/08/2006
• Est. Priority Date: 02/16/2002
• Status: Expired due to Fees

• Current Assignee: Graham Lindley Spruiell
• Original Assignee: Graham Lindley Spruiell
• Inventors: Spruiell, Graham Lindley
• Primary Examiner(s): Dawson, Glenn K.
• Assistant Examiner(s): Mendoza, Michael G.
• Application Number:
  US10/075,088
• Publication Number:
  US 20030154981A1
• Time in Patent Office: 1,634 Days
• Field of Search: 128/205.22, 128/206.28, 128/207.12, 128/200.24, 128/204.18, 128/205.24, 128/205.25
• US Class Current: 128/200.24
• CPC Class Codes: A61M 16/06 Respiratory or anaesthetic masks
• CPC Class Codes: A61M 16/10 Preparation of respiratory gases or vapours
• CPC Class Codes: A61M 2202/0208 Oxygen
• CPC Class Codes: A61M 2209/06 Packaging for specific medical equipment

Abstract

The invention provides an emergency medical kit for use immediately upon the onset of symptoms of an attack of a vascular disease such as a heart attack or a stroke. The emergency medical kit at least includes breathable oxygen in a light weight container and may include medications for preventing thrombosis, inducing arteriolar relaxation or assisting in diminishing oxygen demand by the victim. The kit including oxygen and medication dosage may be prescribed by a physician to a person with a known susceptibility to a serious unexpected attack of a vascular disease. The treatment provided by the contents of the kit is specifically intended to save the life of an attack victim and or to reduce permanent tissue damage in the victim during the time interval between the onset of the attack and the arrival of a professional medical service provider. The kit is lightweight and readily carried by the user or stored in a location for easy access.

Claims

1. A method for increasing a patient'"'"'s chance to survive a sudden ischemic event without suffering permanent tissue damage comprising the steps of:

establishing that the patient has a high risk of suffering the sudden ischemic event;

identifying one or more medications and dosage amounts that would be suitable for the patient to take in combination with breathable oxygen to increase the patient'"'"'s chance to survive the sudden ischemic event without suffering permanent tissue damage in the event that the sudden ischemic event occurs;

prescribing the medications in a form suitable for self-administration during the sudden ischemic event;

providing the patient with a portable emergency medical kit comprising the prescribed medications in the dosage amount identified and in the form suitable for self administration and a portable oxygen tank (20), pressure regulating valve (25), hollow delivery tube (30) and facemask (35) configured to deliver breathable oxygen to the patient at an appropriate pressure and flow rate during the sudden ischemic event;

informing the patient of what symptoms to look for and instructing the patient in the use of the breathable oxygen and the medications in the event that the sudden ischemic event occurs; and

,

instructing the patient to keep the emergency medical kit readily available for use.

2. The method of claim 1 wherein the step of identifying one or more medications and dosage amounts further comprises the step of:

identifying one of magnesium, nitroglycerin, a beta-adrenergic antagonist (Beta-Blocker), a calcium channel blocker and an angiotensin-converting enzyme (ACE) inhibitor.

4. The method of claim 1 wherein the step of identifying one or more medications and dosage amounts further comprises the step of identifying a nitrite selected from the group of, nitroglycerin, isosorbide dinitrate, and isosorbide monitrate.

5. The method of claim 1 wherein the step of identifying one or more medications and dosage amounts further comprises the step of identifying magnesium.

6. The method of claim 1 wherein the step of identifying one or more medications and dosage amounts further comprises the step of identifying aspirin and clopidogrel.

7. The method of claim 1 wherein the step of identifying one or more medications and dosage amounts further comprises the step of identifying aspirin-dipyridamole.

3. A method for increasing a patient'"'"'s chance to survive a sudden ischemic event without suffering permanent tissue damage comprising the steps of:

prescribing one of acetylsalicylic acid, dipyridamole, clopidogrel, heparin and a glycoprotein IIb/IIIa inhibitor in a dosage amount suitable for preventing thrombosis and in a form suitable for self administration;

prescribing breathable oxygen to be administered to the patient as soon as symptoms of the sudden ischemic event occur;

providing the patient with an emergency medical kit containing the prescribed medications and a portable oxygen tank (20), pressure regulating valve (25), hollow delivery tube (30) and facemask (35) configured to deliver breathable oxygen to the patient at an appropriate pressure and flow rate during the sudden ischemic event;

informing the patient of what symptoms to look for and instructing the patient in the use of the breathable oxygen and the medications in the event that the sudden ischemic event occurs; and

,

instructing the patient to keep the emergency medical kit readily available for use.